Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity.
暂无分享,去创建一个
[1] A. Brownlie,et al. Mitoferrin is essential for erythroid iron assimilation , 2006, Nature.
[2] T. Ganz,et al. Iron imports. IV. Hepcidin and regulation of body iron metabolism. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[3] A. Rosato,et al. A NMR Study of the Interaction of a Three-domain Construct of ATP7A with Copper(I) and Copper(I)-HAH1 , 2005, Journal of Biological Chemistry.
[4] L. V. Puchkova,et al. [Identification of the rat ceruloplasmin mRNA isoform putative coded of a protein localized in mitochondria]. , 2005, Molekuliarnaia biologiia.
[5] L. V. Puchkova,et al. Identification of the Putative mRNA Coding for a Mitochondrial Isoform of Rat Ceruloplasmin , 2005, Molecular Biology.
[6] V. Vassiliev,et al. Ceruloplasmin in neurodegenerative diseases , 2005, Brain Research Reviews.
[7] G. Brewer. Anticopper therapy against cancer and diseases of inflammation and fibrosis. , 2005, Drug discovery today.
[8] M. Núñez,et al. Iron and copper metabolism. , 2005, Molecular aspects of medicine.
[9] R. Beynon,et al. The greater susceptibility of North Ronaldsay sheep compared with Cambridge sheep to copper-induced oxidative stress, mitochondrial damage and hepatic stellate cell activation. , 2005, Journal of comparative pathology.
[10] C. Keen,et al. Copper, oxidative stress, and human health. , 2005, Molecular aspects of medicine.
[11] S. Kaler,et al. Downregulation of myelination, energy, and translational genes in Menkes disease brain. , 2005, Molecular genetics and metabolism.
[12] Jian Cai,et al. Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. , 2005, Biochemical and biophysical research communications.
[13] D. Butterfield,et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.
[14] T. Rouault,et al. Iron–sulphur cluster biogenesis and mitochondrial iron homeostasis , 2005, Nature Reviews Molecular Cell Biology.
[15] M. Beal,et al. Mutant Superoxide Dismutase 1 Forms Aggregates in the Brain Mitochondrial Matrix of Amyotrophic Lateral Sclerosis Mice , 2005, The Journal of Neuroscience.
[16] D. Richardson,et al. Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.
[17] G. Rotilio,et al. Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage. , 2005, Biochemical and biophysical research communications.
[18] Klevay Lm. Ischemic heart disease as deficiency disease. , 2004 .
[19] J. Prohaska,et al. Cu, Zn-Superoxide Dismutase is Lower and Copper Chaperone CCS is Higher in Erythrocytes of Copper-Deficient Rats and Mice , 2004, Experimental biology and medicine.
[20] Heather A. O'Neill,et al. Frataxin Acts as an Iron Chaperone Protein to Modulate Mitochondrial Aconitase Activity , 2004, Science.
[21] M. Cazzola,et al. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. , 2004, Blood.
[22] C. Sheline,et al. Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo , 2004, Annals of neurology.
[23] J. Prohaska,et al. Intracellular copper transport in mammals. , 2004, The Journal of nutrition.
[24] L. V. Puchkova,et al. Age-Related Features of Ceruloplasmin Biosynthesis and Distribution in Rats , 2004, Russian Journal of Developmental Biology.
[25] M. Hentze,et al. Balancing Acts Molecular Control of Mammalian Iron Metabolism , 2004, Cell.
[26] J. Valentine,et al. Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Franklin,et al. Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondria. , 2004, Journal of inorganic biochemistry.
[28] M. Cazzola,et al. Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). , 2004, Blood.
[29] G. Rotilio,et al. Mitochondrial Dysfunction in Neurodegenerative Diseases Associated with Copper Imbalance , 2004, Neurochemical Research.
[30] C. Wijmenga,et al. Molecular regulation of copper excretion in the liver , 2004, Proceedings of the Nutrition Society.
[31] A. Jayasurya,et al. Metallothioneins in human tumors and potential roles in carcinogenesis. , 2003, Mutation research.
[32] M. Kruszewski,et al. Labile iron pool: the main determinant of cellular response to oxidative stress. , 2003, Mutation research.
[33] M. L’Abbé,et al. Copper Modulates the Degradation of Copper Chaperone for Cu,Zn Superoxide Dismutase by the 26 S Proteosome* , 2003, Journal of Biological Chemistry.
[34] E. D. Harris. Basic and clinical aspects of copper. , 2003 .
[35] I. Fridovich,et al. Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses. , 2003, Free radical biology & medicine.
[36] Z. Harris,et al. Genetic defects in copper metabolism. , 2003, The Journal of nutrition.
[37] J. Mercer,et al. Molecular and cellular aspects of copper transport in developing mammals. , 2003, The Journal of nutrition.
[38] D. Winge,et al. Assembly of cytochrome c oxidase within the mitochondrion. , 2003, Accounts of chemical research.
[39] P. Fox. The copper-iron chronicles: The story of an intimate relationship , 2003, Biometals.
[40] M. Cazzola,et al. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. , 2003, Blood.
[41] D. Richardson. Friedreich’s ataxia: iron chelators that target the mitochondrion as a therapeutic strategy? , 2003, Expert opinion on investigational drugs.
[42] D. Templeton. The importance of trace element speciation in biomedical science , 2003, Analytical and bioanalytical chemistry.
[43] C. Vulpe,et al. The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. , 2002, Blood cells, molecules & diseases.
[44] M. Cazzola,et al. Mitochondrial ferritin: a new player in iron metabolism. , 2002, Blood cells, molecules & diseases.
[45] Or Kakhlon,et al. The labile iron pool: characterization, measurement, and participation in cellular processes(1). , 2002, Free radical biology & medicine.
[46] B. Bacon,et al. Iron Toxicity and Chelation Therapy , 2002, International journal of hematology.
[47] J. Gitlin,et al. The copper-iron connection: hereditary aceruloplasminemia. , 2002, Seminars in hematology.
[48] M. Marra,et al. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. , 2002, Blood.
[49] C. Sheline,et al. Cofactors of mitochondrial enzymes attenuate copper‐induced death in vitro and in vivo , 2002, Annals of neurology.
[50] L. Powell,et al. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. , 2002, Blood.
[51] Aamir Ahmad,et al. Bilirubin/biliverdin-Cu(II) induced DNA breakage; reaction mechanism and biological significance. , 2002, Toxicology letters.
[52] J. Eaton,et al. Interactions of copper with glycated proteins: Possible involvement in the etiology of diabetic neuropathy , 2002, Molecular and Cellular Biochemistry.
[53] J. Eaton,et al. Molecular bases of cellular iron toxicity. , 2002, Free radical biology & medicine.
[54] P. Rustin,et al. Cytochrome oxidase in health and disease. , 2002, Gene.
[55] R. Hider,et al. Iron: an essential but potentially harmful nutrient , 2002, European journal of clinical investigation.
[56] P. Ponka. Iron Utilization in Erythrocyte Formation and Hemoglobin Synthesis , 2002 .
[57] D. Templeton. Molecular and Cellular Iron Transport , 2002 .
[58] D. Templeton,et al. Transport of Non-Transferrin-Bound Iron by Hepatocytes , 2002 .
[59] F. Petrat,et al. The Chelatable Iron Pool in Living Cells: A Methodically Defined Quantity , 2002, Biological chemistry.
[60] I. Fridovich,et al. Subcellular Distribution of Superoxide Dismutases (SOD) in Rat Liver , 2001, The Journal of Biological Chemistry.
[61] M. Kondoh,et al. Specific induction of metallothionein synthesis by mitochondrial oxidative stress. , 2001, Life sciences.
[62] P. Arosio,et al. A Human Mitochondrial Ferritin Encoded by an Intronless Gene* , 2001, The Journal of Biological Chemistry.
[63] H. Schipper,et al. Proinflammatory cytokines promote glial heme oxygenase‐1 expression and mitochondrial iron deposition: implications for multiple sclerosis , 2001, Journal of neurochemistry.
[64] F. Palau,et al. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review). , 2001, International journal of molecular medicine.
[65] B. Ye,et al. Zinc metallothionein imported into liver mitochondria modulates respiration , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Schaefer,et al. Hepatic iron overload in aceruloplasminaemia , 2000, Gut.
[67] T. Rouault,et al. Distinct iron–sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells , 2000, The EMBO journal.
[68] P. Patel,et al. Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae. , 2000, Human molecular genetics.
[69] Peter Schulz-Knappe,et al. LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity , 2000, FEBS letters.
[70] J. Cooper,et al. Oxidative-phosphorylation defects in liver of patients with Wilson's disease , 2000, The Lancet.
[71] S. Seki,et al. Proteome analysis of rat hepatic stellate cells , 2000, Hepatology.
[72] S. Abboud,et al. A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.
[73] C. Krebs,et al. IscU as a scaffold for iron-sulfur cluster biosynthesis: sequential assembly of [2Fe-2S] and [4Fe-4S] clusters in IscU. , 2000, Biochemistry.
[74] H. Schipper,et al. Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. , 2000, Cellular and molecular biology.
[75] D. Ceccarelli,et al. Iron-Induced Oxidant Stress Leads to Irreversible Mitochondrial Dysfunctions and Fibrosis in the Liver of Chronic Iron-Dosed Gerbils. The Effect of Silybin , 2000, Journal of bioenergetics and biomembranes.
[76] M. Koenig,et al. Recent advances in the molecular pathogenesis of Friedreich ataxia. , 2000, Human molecular genetics.
[77] J. Pourahmad,et al. A comparison of hepatocyte cytotoxic mechanisms for Cu2+ and Cd2+. , 2000, Toxicology.
[78] W. Sly,et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[79] R J Simpson,et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. , 2000, Molecular cell.
[80] J. Cooper,et al. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. , 2000, Human molecular genetics.
[81] R Williamson,et al. Review articles Friedreich ataxia: an overview , 1999 .
[82] E. van den Berg,et al. Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis. , 1999, Leukemia research.
[83] R. Lill,et al. The Essential Role of Mitochondria in the Biogenesis of Cellular Iron-Sulfur Proteins , 1999, Biological chemistry.
[84] M. Ohta,et al. A Case of Hereditary Ceruloplasmin Deficiency with Iron Deposition in the Brain Associated with Chorea, Dementia, Diabetes mellitus and Retinal Pigmentation: Administration of Fresh-Frozen Human Plasma , 1999, European Neurology.
[85] S. Tabrizi,et al. Secondary abnormalities of mitochondrial DNA associated with neurodegeneration. , 1999, Biochemical Society symposium.
[86] H. Koeffler,et al. Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.
[87] Masayuki Yamamoto,et al. A novel mutation of the erythroid‐specific δ‐aminolaevulinate synthase gene in a patient with X‐linked sideroblastic anaemia , 1999, British journal of haematology.
[88] M. Sogorb,et al. Dichlorophenyl phosphoramidates as substrates for avian and mammalian liver phosphotriesterases: activity levels, calcium dependence and stereospecificity. , 1999, Chemico-biological interactions.
[89] M. Delatycki,et al. Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia , 1999, Annals of neurology.
[90] L. Bernier,et al. Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore , 1999, Journal of neurochemistry.
[91] A. Hutchinson,et al. Mutation of a Putative Mitochondrial Iron Transporter Gene (ABC7) in X-Linked Sideroblastic Anemia and Ataxia (XLSA/A) , 1999, Human molecular genetics.
[92] Gregory J. Anderson,et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse , 1999, Nature Genetics.
[93] B. Bergamasco,et al. Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment , 1999, The Italian Journal of Neurological Sciences.
[94] G. Link,et al. Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells. , 1999, The Journal of laboratory and clinical medicine.
[95] I. Mavelli,et al. Decrease of cytochrome c oxidase protein in heart mitochondria of copper-deficient rats , 1998, Biometals.
[96] H. Schipper,et al. Astrocyte Mitochondria: A Substrate for Iron Deposition in the Aging Rat Substantia Nigra , 1998, Experimental Neurology.
[97] R. Williamson,et al. The correlation of clinical phenotype in Friedreich ataxia with the site of point mutations in the FRDA gene , 1998, Neurogenetics.
[98] G. Link,et al. Pathophysiology of Iron Overload a , 1998, Annals of the New York Academy of Sciences.
[99] T. Fujiwara,et al. Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia , 1998, Journal of Human Genetics.
[100] M. Cooper,et al. Localization of the Wilson's disease protein product to mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[101] J. Gitlin,et al. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. , 1998, The American journal of clinical nutrition.
[102] G. Link,et al. Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. , 1998, The Journal of laboratory and clinical medicine.
[103] M. Hambidge,et al. Clinical conditions altering copper metabolism in humans. , 1998, The American journal of clinical nutrition.
[104] E. Bradbury,et al. GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases. , 1998, Molecular cell.
[105] B. Guiard,et al. The ABC transporter Atm1p is required for mitochondrial iron homeostasis , 1997, FEBS letters.
[106] B. Van Houten,et al. Preferential mitochondrial DNA injury caused by glucose oxidase as a steady generator of hydrogen peroxide in human fibroblasts. , 1997, Mutation research.
[107] F. Kuipers,et al. Differences in hepatic processing of dietary and intravenously administered copper in rats , 1997, Hepatology.
[108] R. Wildman,et al. Newer Findings on a Unified Perspective of Copper Restriction and Cardiomyopathy 1 , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[109] D. Pessayre,et al. Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. , 1997, Gastroenterology.
[110] M. Pandolfo,et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.
[111] R. Wolff,et al. The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression* , 1997, The Journal of Biological Chemistry.
[112] R. Palmiter,et al. Metallothioneins in brain--the role in physiology and pathology. , 1997, Toxicology and applied pharmacology.
[113] B. Van Houten,et al. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[114] A Dürr,et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.
[115] M. C. Ellis,et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.
[116] D. Richardson,et al. Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism. , 1996, Blood.
[117] S. Fucharoen,et al. Liver injury due to iron overload in thalassemia: histopathologic and ultrastructural studies , 1996, Biometals.
[118] P. Patel,et al. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.
[119] G. Link,et al. Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction. , 1996, The Journal of laboratory and clinical medicine.
[120] I. Sternlieb,et al. An array of mitochondrial alterations in the hepatocytes of long‐evans cinnamon rats , 1995, Hepatology.
[121] G. Gyapay,et al. The Friedreich ataxia critical region spans a 150-kb interval on chromosome 9q13. , 1995, American journal of human genetics.
[122] H. Morita,et al. Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a japanese family , 1995, Annals of neurology.
[123] H. Schipper,et al. A Cellular Stress Model for the Sequestration of Redox‐Active Glial Iron in the Aging and Degenerating Nervous System , 1995, Journal of neurochemistry.
[124] B. Garty,et al. Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. , 1995, American journal of medical genetics.
[125] B. Neuschwander‐Tetri,et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. , 1994, Gastroenterology.
[126] Y. Wada,et al. Studies on familial hypotransferrinemia: unique clinical course and molecular pathology. , 1993, American journal of human genetics.
[127] R. Sokol,et al. Abnormal hepatic mitochondrial respiration and cytochrome C oxidase activity in rats with long-term copper overload. , 1993, Gastroenterology.
[128] H. Faille,et al. Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria , 1993, European journal of clinical investigation.
[129] B. Halliwell,et al. Biologically relevant metal ion‐dependent hydroxyl radical generation An update , 1992, FEBS letters.
[130] I. A. Skulskii,et al. Interaction of Cu+ with mitochondria. , 1991, Acta chemica Scandinavica.
[131] G. Waldrop,et al. Effect of albumin on net copper accumulation by fibroblasts and hepatocytes. , 1990, The American journal of physiology.
[132] J. Kumaratilake,et al. Intracellular distribution of copper in the liver of copper-loaded sheep--a subcellular fractionation study. , 1989, Journal of comparative pathology.
[133] C. Craven,et al. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[134] Y. Ueda,et al. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease. , 1979, The Journal of clinical investigation.
[135] D. Massart,et al. The determination of Cu, Zn, and Mn in subcellular rat liver fractions. , 1977, Analytical biochemistry.
[136] D. Loukopoulos,et al. Role of Copper in Mitochondrial Iron Metabolism , 1976 .
[137] T. Sourkes,et al. Intracellular distribution of copper in the liver during chronic administration of copper sulfate to the rat. , 1971, Toxicology and applied pharmacology.
[138] J. Grasso,et al. A Comparative Electron Microscopic Study of Refractory and Alcoholic Sideroblastic Anaemia , 1969, British journal of haematology.
[139] G. Papanikolaou,et al. Prevalence of the G320V mutation of the HJV gene, associated with juvenile hemochromatosis, in Greece. , 2004, Haematologica.
[140] D. Girelli,et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.
[141] J. Tolmie,et al. Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. , 2000, Blood.
[142] Harris Ed. Ceruloplasmin and iron: vindication after 30 years. , 1999 .
[143] P. Patel,et al. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. , 1998, American journal of human genetics.
[144] P. Ponka. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. , 1997, Blood.
[145] P. Ponka. Tissue-Specific Regulation of Iron Metabolism and Heme Synthesis: Distinct Control Mechanisms in Erythroid Cells , 1997 .
[146] Giuseppe Di Fazio,et al. Interaction between Cu2+ ions and cholic acid derivatives followed by polarography. , 1995, Journal of pharmaceutical sciences.
[147] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[148] G. Sutherland,et al. Erythroid 5-aminolevulinate synthase is located on the X chromosome. , 1990, American journal of human genetics.
[149] D. Weatherall,et al. Iron-chelating therapy. , 1988, Critical reviews in clinical laboratory sciences.
[150] E. Russanov,et al. Studies on lipid peroxidation in rat liver by copper deficiency. , 1981, The International journal of biochemistry.
[151] T. Tephly,et al. A possible role of copper in the regulation of heme biosynthesis through ferrochelatase. , 1975, Advances in experimental medicine and biology.
[152] M. Losowsky,et al. Microspectrophotometric and electron microscopic studies of bone marrow in hereditary sideroblastic anaemia. , 1971, Acta haematologica.